Skip to main content

Guidance and regulation

Skip to results
1,557 results sorted by Most viewed
From Closed organisation: Public Health England (PHE)
  • This resource provides details of datasets or sources of information available to examine the impact of alcohol licensing.

  • Epidemiological protocols for comprehensive assessment of early influenza A (H7N9) cases and their close contacts in the United Kingdom.

  • Executive summary of quality assurance (QA) visit to Berkshire held on 17 October 2019.

  • This external quality assessment (EQA) scheme is suitable for laboratories that routinely monitor bottled and mineral water for indicator organisms.

  • This external quality assessment (EQA) scheme is suitable for laboratories that routinely monitor bottled and mineral waters for indicator organisms.

  • Advice for people who inject drugs (PWID) on reducing the risk of wound botulism.

  • Breast screening services can send this pack to GP practices before their patients are invited for screening, to ensure invitations go to the correct people.

  • Guidance for breast screening services undertaking mammogram reading for another service.

  • This leaflet is for women who have had only partial or incomplete mammography during NHS breast screening.

  • Guidance for breast screening services on assistant practitioners (APs) working with remote radiographic supervision.

  • Estimates of the main causes of death and disability, attributable risk factors and the effect of deprivation, modelled for England and its regions.

  • Business definitions for young people drug and alcohol treatment providers to input data onto the national drug treatment monitoring system (NDTMS).

  • Guidelines for environmental health practitioners (EHP) on the risks of CO for occupants of residential premises.

  • Information for parents on PHE’s position regarding the use of porcine gelatine in Fluenz, the children’s nasal spray flu vaccine.

  • Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing LA and NHS commissioned chlamydia tests.

  • Leaflets for patients identified as at increased risk of Creutzfeldt-Jakob Disease (CJD) and for healthcare professionals involved in the care or notification of these patients.

  • A guide that supports the methods used for all place of death indicators as classified by Office for National Statistics (ONS) death certificate data.

  • Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.

  • A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).

  • Advice for parents and carers about the main risks children may be particularly vulnerable to and information about available help and support.